Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials. Annals of the rheumatic diseases. pp. 1314-1315. [Online].